APO LMV 300 (Lamivudine 300 mg)

Pill imprint APO LMV 300 has been identified as Lamivudine 300 mg.

Lamivudine is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO LMV 300

Lamivudine 300 mg APO LMV 300 Front
Lamivudine 300 mg APO LMV 300 Back
Lamivudine 300 mg APO LMV 300
Lamivudine 300 mg APO LMV 300
Lamivudine
Imprint:
APO
LMV 300
Strength:
300 mg
Color:
Gray
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)